A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...

Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also play a ...

(Mass Appeal) – March is Multiple Sclerosis Awareness Month and because there is a lot of misinformation out there, as well as some cutting edge diagnostics, we’ve asked Dr. Hebatalla Elhusseiny, an ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the ...

I was officially diagnosed with multiple sclerosis (MS) in 2021, but I had symptoms of the condition for nearly two decades before that. I remember being 17 and having what's known as optic neuritis — ...

New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) reveals that menopause may significantly influence how ...